BTIG analysts said today that Beta Bionics expects to launch a new insulin patch pump system in the U.S. by the end of 2027.

New study results demonstrated the safety and efficacy of the MannKind Afrezza inhaled insulin offering for children with ...

(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.

One of the leaders in continuous glucose monitoring (CGM) technology, Dexcom (Nadsaq:DXCM) continues to expand its ...

It's been a busy couple of years for Tandem Diabetes Care (Nasdaq:TNDM) and it doesn't look like slowing down any time soon.